6.
Shin D, Yuk J, Lee H, Lee S, Son J, Harding C
. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol. 2010; 12(11):1648-65.
PMC: 2970753.
DOI: 10.1111/j.1462-5822.2010.01497.x.
View
7.
Lemire J
. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 1995; 53(1-6):599-602.
DOI: 10.1016/0960-0760(95)00106-a.
View
8.
Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T
. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981; 78(8):4990-4.
PMC: 320317.
DOI: 10.1073/pnas.78.8.4990.
View
9.
Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C
. VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J. 2000; 14(10):1455-63.
DOI: 10.1096/fj.14.10.1455.
View
10.
Bellecave P, Sarasin-Filipowicz M, Donze O, Kennel A, Gouttenoire J, Meylan E
. Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system. Hepatology. 2010; 51(4):1127-36.
DOI: 10.1002/hep.23426.
View
11.
Wrange O, Eriksson P, Perlmann T
. The purified activated glucocorticoid receptor is a homodimer. J Biol Chem. 1989; 264(9):5253-9.
View
12.
Roy S, Frodsham A, Saha B, Hazra S, Mascie-Taylor C, Hill A
. Association of vitamin D receptor genotype with leprosy type. J Infect Dis. 1998; 179(1):187-91.
DOI: 10.1086/314536.
View
13.
Arbelle J, Chen H, Gaead M, Allegretto E, Pike J, Adams J
. Inhibition of vitamin D receptor-retinoid X receptor-vitamin D response element complex formation by nuclear extracts of vitamin D-resistant New World primate cells. Endocrinology. 1996; 137(2):786-9.
DOI: 10.1210/endo.137.2.8593831.
View
14.
Rigby W, Stacy T, Fanger M
. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest. 1984; 74(4):1451-5.
PMC: 425314.
DOI: 10.1172/JCI111557.
View
15.
Mangelsdorf D, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K
. The nuclear receptor superfamily: the second decade. Cell. 1995; 83(6):835-9.
PMC: 6159888.
DOI: 10.1016/0092-8674(95)90199-x.
View
16.
Heaney R
. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr. 2004; 80(6 Suppl):1706S-9S.
DOI: 10.1093/ajcn/80.6.1706S.
View
17.
Norman A, Adams D, Collins E, Okamura W, Fletterick R
. Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3). J Cell Biochem. 1999; 74(3):323-33.
View
18.
Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R
. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30.
DOI: 10.1210/jc.2011-0385.
View
19.
Morita A, Iki M, Dohi Y, Ikeda Y, Kagamimori S, Kagawa Y
. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study. Int J Epidemiol. 2004; 33(5):979-88.
DOI: 10.1093/ije/dyh245.
View
20.
Safadi F, Thornton P, Magiera H, Hollis B, Gentile M, Haddad J
. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999; 103(2):239-51.
PMC: 407885.
DOI: 10.1172/JCI5244.
View